Merger and acquisition speculation is one of the most interesting and exciting elements of the stock market. Sometimes both activist institutions and private investors can leverage deals or stop deals from happening depending on how many shares they control in…
Free Articles
I bought $SLTM @ $2.30
I bought $SLTM @ $2.30 — as I informed premium subs, I expected this move today to $2.25. VOCE is likely to release another letter soon, and company is likely , in my opinion to be acquired before end of…
Trius Acquired Last Week, Tetraphase Could Be Next
Written by Scott Matusow, Mr.Matusow holds a position in the company featured in this article. Last week, Cubist Pharmaceuticals Inc. (CBST) agreed to buy Trius Therapeutics Inc. (TSRX) and Optimer Pharmaceuticals Inc. (OPTR) for as much as $1.62 billion. Cubist…
Biodel Expecting To Release Top-Line Data Soon
Biodel (BIOD) is expecting top-line Phase II data for BIOD-123 to be released in the third quarter 2013. With the market for these products estimated to be about $10 billion in value, good results for Biodel’s product would be a…
Significant Near Term Catalyst Should Further Rally Keryx Pharmaceuticals
Recently, we have detailed companies that have released positive Phase III data because we believe several of these companies continue to be under speculation value. Companies who have strong management, cash, and a strong pipeline can be very profitable for…
Corrected Video: Market Commentary + Trade Watch Update 7/13/13
Some commentary from me on recent market action plus chart commentary on some of our recent picks. $GTXI $TSRX $SGMO $DRRX $SGMO $FB $BBY
4 Biopharmas On Catalyst Watch List For Week 7/8/2013
Stockmatusow.com has compiled 4 biopharmas with significant near-term catalysts ahead that should drive their respective stock prices higher. We think each of these companies should also be looked at for speculation investments. Since the companies listed below are smaller caps,…
Cempra’s Platform Potentially Worth Billions In Battling Superbugs And MRSA
Written by StockMatusow.com writers Scott Matusow and Kyle Dennis. Mr.Matusow and Mr. Dennis hold positions in Cempra. During volatile market conditions, many investors decide to sell to protect profit. Investors have seen extraordinary gains so far in 2013 and stocks…
Biodel Primed To Capitalize On Next Generation Treatments In The $10B Diabetes Market
Glucose is one of the most important chemical structures because it is essential in providing the body with energy. It is integral in the chemical process called aerobic respiration, which generates a usable form of energy. Glycolysis is the beginning…
Wednesday’s Biotech Catalyst Trade Watch List
Today, I list four biotech companies with significant near-term catalysts ahead. Under normal market conditions, these stocks should see decent to very strong appreciation in the short-term. There are various ways to play these catalyst trades. Traders and investors can…
